Trialfacts

MARCH 1, 2023

Researchers and Actinogen Medical are currently exploring a new potential treatment, Xanamem®, for those with depressive symptoms who are also experiencing cognitive symptoms. If you have been diagnosed with depression and would like to contribute to the development of a potential new treatment, then consider joining this research study!

Research 52

Research Clinical Trials Clinical Trials Containment 52

The Pharma Data

SEPTEMBER 3, 2020

Researchers have discovered that an aggressive form of pancreatic cancer ‘hijacks’ the immune system’s response and therefore is more likely to respond to treatment with immunotherapy, raising hopes for new targets in the fight against the disease.

Research 52

Research Genetic Analysis Gene Scientist 52

Roots Analysis

OCTOBER 24, 2023

Owing to the advancement in clinical pharmacology and oncology domain, and the rising demand for targeted therapeutics and precision medicines, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have become one of the key areas of interest to researchers and drug manufacturers across the globe.

Manufacturing 40

Manufacturing Hormones Contamination Containment 40

Olympian Clinical Research

NOVEMBER 6, 2023

While the exact cause is unknown, factors like genetics, inflammation, and hormones play a role. Here are some common triggers of HS: Hormonal Changes: Many individuals with HS report flare-ups during periods of hormonal change, such as menstruation, pregnancy, or menopause.

Hormones 52

Hormones Doctors Doctor Clinical Trials 52

XTalks

MAY 31, 2023

The research demonstrates that excessive intake of table salt can elevate several indicators for dementia and Alzheimer’s disease. The research team utilized a mouse model, feeding the mice a high sodium solution (two percent sodium chloride) in their drinking water for 12 weeks, and noted their blood pressure throughout the study.

Protein 111

Protein Hormones Containment Branding 111

Delveinsight

JANUARY 5, 2021

Pfizer and OPKO Health: A step closer to FDA Nod for pediatric growth hormone deficiency (GHD) drug, Somatrogon. Pfizer and Opko had joined hands in 2014 to develop somatrogon , a pediatric growth hormone deficiency (GHD) drug. FDA Emergency Use Authorization for SCONE Medical’s Novel Aerosol Infection Containment Device.

Hormones 52

Hormones FDA Approval Trials Drugs 52

XTalks

MARCH 29, 2021

According to a study by researchers at the National Institutes of Health (NIH), moderate caffeine intake could lead to small babies. The research found that even consumption of less than the recommended moderate amount of 200 mg of caffeine per day for adults, which is about two cups of coffee, posed an increased risk to the fetus.

Genotype 98

Genotype Allergies Hormones Research 98

Olympian Clinical Research

MARCH 3, 2023

When AD develops after your 18th birthday, it is known as adult-onset atopic dermatitis. However, it is possible for adults of all ages to develop eczema. When we are under stress, our bodies release cortisol, a hormone that can weaken the skin’s natural barrier and make it more susceptible to irritation and inflammation.

Clinical Research 52

Clinical Research Production Containment Research 52

Drug Discovery World

AUGUST 21, 2023

Medications containing semaglutide such as Ozempic, licensed for diabetes, and Wegovy, for weight loss, are being studied to see if they can treat a range of different conditions, including addiction and dementia. GLP-1 is a hormone that is produced naturally in the brain and the gut in response to food ingestion.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Camargo

NOVEMBER 29, 2021

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Essentially, a biologic is a product that is produced from living organisms or that contains components of living organisms.

Development 180

Development Protein Production Hormones 180

The Pharma Data

AUGUST 15, 2021

The WELIREG label contains a boxed warning that exposure to WELIREG during pregnancy can cause embryo-fetal harm. Advise patients of these risks and the need for effective non-hormonal contraception. WELIREG can render some hormonal contraceptives ineffective. WELIREG can render some hormonal contraceptives ineffective.

Hormones 52

Hormones Clinical Trials Clinical Trials Trials 52

Delveinsight

DECEMBER 7, 2020

For instance, the shortage of healthcare professionals can be tackled by creating better diagnostic and treatment procedures, integrating solutions developed by physicians worldwide, and providing them seamlessly over a platform accessed by all practicing physicians. In May 2018, Ava raised about $30 million in a Series B round.

Protein 56

Protein Insulin Hormones FDA Approval 56

The Pharma Data

AUGUST 30, 2021

“With deeper analyses in overall survival and quality of life in breast and prostate cancer, as well as exciting research in other solid tumors, our data at ESMO demonstrates our ambition to transform lives and renew patients’ hope for the future.”. Abstract Title. Abstract Number. Prostate Cancer. 177 Lu-PSMA-617. Disclaimer.

HR 52

HR Production Trials Containment 52

Pfizer

JANUARY 27, 2023

Pfizer Responds to Research Claims carterda Fri, 01/27/2023 - 19:48 Pfizer Responds to Research Claims Friday, January 27, 2023 - 08:00pm Share New York, N.Y., In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research.

Research 112

Research Vaccination Vaccine Drugs 112

XTalks

NOVEMBER 9, 2023

XTALKS WEBINAR: The Evolution of the Cardiovascular Clinical Development Landscape and Potential Role of GLP-1 RAs Live and On-Demand: Wednesday, December 6, 2023, at 11am EST (4pm GMT/UK) Register for this free webinar to learn about successful study outcomes in developing GLP1s to new therapeutic areas within cardiovascular medicine and more.

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59

The Pharma Data

MAY 15, 2021

Physique developers around the world are amazed that… …using natural food and training techniques, you can increase your body’s normal production of growth producing hormone! Going back to the drawing board and looking for ways to restart my body’s natural hormone output, I came across an amazing discovery.

Hormones 52

Hormones Production Development Containment 52

Pfizer

JANUARY 27, 2023

It was developed to be administered orally so that it can be prescribed early after infection, potentially helping patients avoid severe illness (which can lead to hospitalization and death). Contraception: Use of ritonavir may reduce the efficacy of combined hormonal contraceptives.

Marketing 75

Marketing Production Drugs Licensing 75

The Pharma Data

FEBRUARY 8, 2021

“The TITAN final analysis data confirm the long-term clinical benefit and consistent safety profile of ERLEADA ® plus ADT without a compromise in health-related quality of life,” said Mary Guckert, RN, MSN, Vice President, Development Leader, Prostate Cancer, Janssen Research & Development, LLC.

HR 52

HR Hormones Development Production 52

Pfizer

AUGUST 15, 2022

It was developed to be administered orally so that it can be prescribed early after infection, potentially helping patients avoid severe illness (which can lead to hospitalization and death). Loss of therapeutic effect of PAXLOVID and possible development of viral resistance. FDA Emergency Use Authorization Statement. 08.11.2022.

Drugs 99

Drugs Vaccination Vaccine In-Vitro 99

Drug Discovery World

AUGUST 31, 2023

Researchers have identified stem cells in the human thymus for the first time, representing a potential new target to understand immune diseases and cancer. Until now, scientists believed it didn’t contain ‘true’ epithelial stem cells, but only progenitors arising in foetal development.

Research 59

Research Immune Response Scientist Hormones 59

The Pharma Data

AUGUST 17, 2021

Mismatch repair-deficient tumours contain abnormalities that affect the proper repair of DNA when copied in a cell [i]. GSK is responsible for the ongoing research, development, commercialization, and manufacture of each of these Products under the Agreement. Initiate hormone replacement as clinically indicated.

FDA Approval 52

FDA Approval Antibody DNA Hormones 52

The Pharma Data

OCTOBER 14, 2020

14, 2020 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the U.S. PLYMOUTH MEETING, Pa. and CHICAGO , Oct.

FDA Approval 52

FDA Approval Hormones Production Drugs 52

The Pharma Data

NOVEMBER 24, 2020

25, 2020 /CNW/ – On August 21, 2020 , Health Canada approved Lynparza® (olaparib), for the treatment of adult patients with deleterious or suspected deleterious germline and/or somatic BRCA or ATM- mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with a new hormonal agent (NHA).

Gene 52

Gene Hormones DNA Medicine 52

XTalks

MARCH 1, 2021

Reports of a new condition dubbed “mask-associated dry eye” have been coming out of vision care centers in the country, prompting researchers to look at the effects of face masks on the delicate tear film responsible for protecting the eye. Patients given steroids were at greater risk of developing cataracts and glaucoma. Dr. Jones.

Sales 119

Sales Drugs Life Science Containment 119

The Pharma Data

SEPTEMBER 16, 2020

New integrated analyses from our tumour agnostic Rozlytrek ® (entrectinib) clinical development programme. Roche’s Chief Medical Officer and Head of Global Product Development. “As SCLC is distinguished from other lung cancer subtypes due to its aggressive nature, rapid growth and early development of metastatic disease.

HR 52

HR Medicine Hormones Trials 52

The Pharma Data

MAY 6, 2021

These companies offer unique diabetes management platforms that will be compatible with Lilly ‘s Tempo Pen (approved in several global markets) and Tempo Smart Button (currently in late-stage development) to support people with diabetes and healthcare professionals. About DexCom Inc. DexCom, Inc. About Glooko Inc.

Insulin 52

Insulin Medicine Production Hormones 52

The Pharma Data

APRIL 27, 2021

Roche’s Chief Medical Officer and Head of Global Product Development. “We Tecentriq’s extensive development programme includes multiple ongoing and planned Phase III studies across different lung, genitourinary, skin, breast, gastrointestinal, gynaecological, and head and neck cancers.

Medicine 40

Medicine In-Vitro Antibody Development 40

The Pharma Data

APRIL 23, 2021

GSK is responsible for the ongoing research, development, commercialisation, and manufacture of each of these products under the Agreement. containing regimen. Hormone replacement therapy for endocrinopathies should be instituted as warranted. In the patients who developed anti?JEMPERLI World Cancer Research Fund.

Antibody 52

Antibody Hormones Licensing Licensing 52

Pfizer

DECEMBER 13, 2022

It was developed to be administered orally so that it can be prescribed early after infection, potentially helping patients avoid severe illness (which can lead to hospitalization and death). Loss of therapeutic effect of PAXLOVID and possible development of viral resistance . For more information, please visit www.PAXLOVID.com. .

Drugs 110

Drugs Licensing Licensing Production 110

XTalks

FEBRUARY 7, 2023

Current treatments for HR+ breast cancer patients include hormonal therapies, chemotherapies for those that do not respond to hormonal therapy alone and targeted therapies, either stand-alone or in combination with hormonal therapies. Trodelvy contains a monoclonal antibody linked to the anticancer cytotoxic drug SN-38.

HR 52

HR Hormones FDA Approval Antibody 52

Trialfacts

NOVEMBER 30, 2023

Stuart Phillips IRB: This study has been reviewed and approved by the Hamilton Integrated Research Ethics Board (HiREB) under Project #16408 About the Study We all know that resistance training is a powerful tool to rebuild lost muscle mass, but did you know that what you eat plays a crucial role in enhancing these effects? Why Participate?

Protein 52

Protein Research Hormones Containment 52

XTalks

APRIL 29, 2022

Tirzepatide is a novel investigational obesity treatment that contains mimetics of two hormones that are involved in regulating appetite in a single peptide: a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist and a GLP-1 (glucagon-like peptide-1) receptor agonist. percent and 22.5 billion in 2020 to $5.42

Trials 98

Trials Drugs FDA Approval Clinical Trials 98

Olympian Clinical Research

MARCH 31, 2023

If you’re experiencing moderate-to-severe pain caused by endometriosis and have had a surgical diagnosis, consider learning more about endometriosis research through the ELARIS EM-COC Study at Olympian Clinical Research by calling (727) 935-0508.

Hormones 52

Hormones Clinical Research Research Containment 52

pharmaphorum

JULY 28, 2022

Alnylam Pharma has made a name for itself, developing gene-silencing therapies for rare disorders, but its latest discovery could take it into a much larger category – metabolic and cardiovascular disease.

Biobanking 52

Biobanking Gene Gene Silencing Drugs 52

Pfizer

DECEMBER 20, 2022

It was developed to be administered orally so that it can be prescribed early after infection, potentially helping patients avoid severe illness (which can lead to hospitalization and death). Loss of therapeutic effect of PAXLOVID and possible development of viral resistance. For more information, please visit www.PAXLOVID.com.

Drugs 69

Drugs Licensing Licensing Containment 69

The Pharma Data

NOVEMBER 24, 2020

The difference between pill users and non-users was small, and the findings do not prove a cause-and-effect relationship, the researchers stressed. Fluctuating hormone levels are suspected to be the reason, explained Nwaru, of the University of Gothenburg in Sweden. Why would hormones matter? ” © 2020 HealthDay.

Hormones 52

Hormones Doctors Doctor Allergies 52

XTalks

AUGUST 2, 2023

We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. is a global pharmaceutical company, working across both developed and emerging markets. It contains the antiviral medications nirmatrelvir and ritonavir.

Sales 98

Sales Manufacturing FDA Approval Life Science 98